Google announced on Wednesday that it has obtained FDA clearance for the Pixel Watch 3’s “Lack of Pulse Detection” function and will likely be launching it within the U.S. on the finish of March.
The function can detect when a consumer’s coronary heart stops beating as a result of an occasion like main cardiac arrest, respiratory or circulatory failure, overdose, or poisoning. If the watch detects a lack of pulse, it can ask the consumer if they’re okay. If they’re unresponsive, the watch will routinely place a name to emergency companies for doubtlessly life-saving care.
Lack of Pulse Detection first launched within the EU in September 2024, and is at present out there in 14 international locations.
When Google introduced the function ultimately 12 months’s Made By Google occasion, the corporate famous that the watch determines a lack of pulse occasion by not solely checking a consumer’s pulse, however by additionally different physiological and movement knowledge. It then ties these components collectively through a wise AI-driven algorithm.
Google notes that “Lack of Pulse Detection might not detect each occasion of a lack of pulse and isn’t supposed for customers with preexisting coronary heart circumstances or those that require cardiac monitoring. It doesn’t diagnose or deal with any medical situation or present follow-up care. Emergency calling relies on name performance corresponding to your telephone or watch being charged and having sufficient mobile connectivity.”
The brand new function joins Pixel Watch’s different security and well being options, together with Automotive Crash Detection, Fall Detection, Irregular Coronary heart Rhythm Notifications, and the ECG app.